Mainolfi Nello Insider Trades

Insider Trading History

Track insider trading activity for Mainolfi Nello. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $10.1M 90,000 shares
Last Trade
Jul 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.96M 50,000 shares
$119.24
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $74.7M 666,568 shares
Last Trade
Jul 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.95M 50,000 shares
$119.00
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $80.3M 716,568 shares
Last Trade
Jul 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.96M 50,000 shares
$119.24
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $83.7M 746,568 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.14M 80,000 shares
$114.20
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $15.2M 135,559 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.14M 80,000 shares
$114.20
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $83.5M 744,685 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.22M 80,000 shares
$115.30
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $76.1M 679,190 shares
Last Trade
Apr 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.44M 30,000 shares
$81.18
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $24.2M 215,559 shares
Last Trade
Apr 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 30,000 shares
$81.51
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $78M 696,195 shares
Last Trade
Apr 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 30,000 shares
$81.51
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $24.1M 215,000 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4M 215,000 shares
$90.10
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $27.5M 245,559 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 30,000 shares
$90.68
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $78M 696,195 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 30,000 shares
$90.68
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $75.8M 676,431 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.71M 30,000 shares
$90.25
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $74.7M 666,195 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 3,118 shares
$72.41
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $50.1M 446,882 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 3,118 shares
$72.41
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $75M 669,091 shares
Last Trade
Dec 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.34M 30,000 shares
$78.06
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $77.7M 693,077 shares
Last Trade
Dec 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.33M 30,000 shares
$77.81
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $30.9M 275,559 shares
Last Trade
Dec 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.33M 30,000 shares
$77.81
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $30.5M 272,505 shares
Last Trade
Dec 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 2,595 shares
$82.07
$112.08
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $74.3M 663,077 shares
Last Trade
Dec 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 2,595 shares
$82.07
$112.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up